ATS Medical, Inc.
|
3905 Annapolis Lane, Suite 105
Minneapolis, MN 55447 USA
United States |
| Tel: |
1/800 399-1381 |
| URL: |
http://www.atsmedical.com |
|
 |
| Primary Symbols & Exchanges: |
| ATSI - NASDAQ |
| - Berlin-Bremen Stock Exchange |
|
|
| Primary Industry: |
| Medical Devices & Diagnostics |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is to develop manufacture and market medical devices primarily for use by cardiovascular or cardiothoracic surgeons during cardiac surgery. The heart valve manufactured is used to treat heart valve diseases caused by the natural aging process, rheumatic heart disease, prosthetic valve failure and congenital defects. The Group's product is designed to advance the standard of existing mechanical heart valves by combining a proprietary open pivot design and other innovative features with the widely accepted biocompatibility and durability of pyrolytic carbon. It holds an exclusive, royalty-free, worldwide license to an open pivot, bileaflet mechanical heart valve design. It markets its products in the United States, Europe, Japan and Canada. In June 2007, it acquired the surgical cryoablation business of Cryocath Technologies. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on ATS Medical, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
